CPHA Canvax

Paul A. Offit, MD, discusses at what point a vaccine has been studied enough in order to recommend its use. He talks specifically about the HPV vaccine.

Rating See Comments Ratings

Category:

Vaccine Safety and Development,Research and Development,Vaccine Development Vaccine Safety and Development
Research and Development
Vaccine Development

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.